SYRINGA
ActiveSummary
SYRINGA has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €368,004. Equity is growing by about 23% per year across the filed financial years. Its solvency ranks better than 61% of 2,065 sector peers (NACE 73, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
15-10
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 76 days late
20-01
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format · 173 days late
2024
31-12
Financial
Equity above €1mequity €1.1m ▲24.7%
A profit in every financial year since 2020 builds equity to €1.1m.
11-11
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format · 103 days late
2023
31-12
Financial
Weakest financial yearnet €143,053 ▼33.3%
Net result drops to €143,053, the lowest in the series; recovery starts the following year.
15-12
Gazette deed
Appointment: PILAX (director)Permanent representative: Bart Deckers3 facts ▸
Gazette deed
Appointment: PILAX (director)
Permanent representative: Bart Deckers3 facts ▸
- General meeting, 15-10-2023
- Director appointment, PILAX (director)
- Permanent representative, Bart Deckers
25-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 25 days late
2022
22-12
NBB filing
Annual accounts filed
financial year 2021 · micro format · 144 days late
2021
31-12
Financial
Equity above €500,000equity €559,971 ▲42.5%
A profit in every financial year since 2020 builds equity to €559,971.
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.